NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

LATE-BREAKING DATA DEMONSTRATE ABBOTT’S FREESTYLE® LIBRE SYSTEM SUPPORTS HEALTH EQUITY FOR MILLIONS OF AMERICANS LIVING WITH DIABETES

by Ed Johnson
June 14, 2021
A A

– Comparative data presented at the American Diabetes Association 81st Scientific Sessions show Abbott’s diabetes technology delivers the same reductions of HbA1c and acute complications(1,2) as the competitor systems while reaching a much wider, more diverse population

– Priced at a third of the cost of other available continuous glucose monitoring systems(3), data suggests increasing use of FreeStyle Libre system could save Medicaid millions annually(4) by reducing costly complications

– The groundbreaking FreeStyle Libre portfolio has been extensively studied with real-world data from more than 1 million users(5) and clinical evidence, showing it helps people with diabetes significantly improve their health and quality of life(6)

Abbott (NYSE: ABT) today announced late-breaking data that showed FreeStyle Libre, the world’s leading7 continuous glucose monitoring (CGM) system, can support health equity through access to more affordable, life-changing technology for Americans living with diabetes, including those in underserved communities. 

Presented at the American Diabetes Association® (ADA) 81st Scientific Sessions, the data demonstrate meaningful outcomes for people with diabetes using FreeStyle Libre system, including reductions in HbA1C levels, acute diabetes events and all-cause hospitalizations1,2. Globally priced at a third of the cost of other CGMs3, the FreeStyle Libre technology is widely available to people with diabetes, reaching more diverse and at-risk populations than other systems. Notable findings include:

  • FreeStyle Libre users reflect the diverse population of people with type 1 and type 2 diabetes (Abstract 67-LB, Abstract 68-LB): In comparative real-world data for U.S.-only matched patient groups, the FreeStyle Libre system was shown to achieve the same health benefits, including reductions in HbA1C levels and acute complications (hypoglycemia and hyperglycemia), while being accessible to a greater population of people with diabetes compared to other competitor CGM systems. Demographic data from these studies show that FreeStyle Libre users more closely represent America’s diverse type 1 and type 2 diabetes population, including older people, those living in rural areas, people of color and those with higher rates of comorbidities.
  • Increased use of CGM could save Medicaid millions annually while reducing complications (Abstract 136-LB): Using a CGM compared to traditional blood glucose monitoring with fingersticks can reduce potentially harmful and expensive complications, leading to an overall cost savings for individuals living with type 1 and type 2 diabetes. Cost analysis data showed that increasing the population of FreeStyle Libre users by 10% could save the Medicaid budget $23 million in one year due to the reduction in complications.

“Abbott is helping to close the health disparity gap for the millions of people living with diabetes. We designed FreeStyle Libre system to be broadly accessible to all those who need it, no matter a person’s income level, race or background,” said Mahmood Kazemi, M.D., divisional vice president, global medical and scientific affairs and chief medical officer, Diabetes Care, Abbott. “This new data adds to the unparalleled clinical evidence and real-world data from more than 1 million users demonstrating the positive impacts — in both health and equity — that come from the significant cost-savings of Abbott’s life-changing continuous glucose monitoring technology.”

Supporting Health Equity

Despite technological advancements in diabetes care, health inequity is increasing across many underserved populations, including low-income families, individuals with disabilities, older adults and people of color. Individuals with diabetes span a diverse population and it is critical that everyone living with diabetes has access to affordable and easy-to-use CGM systems that work. 

More than 75 million Americans rely on Medicaid8. This often-overlooked population is twice as likely to be living with diabetes and CGM access is limited by many state Medicaid programs. The median percentage of Medicaid beneficiaries with HbA1c of more than 9% (indicating poor control of diabetes) is about 39%9, more than double the corresponding national average of 16%10.  

“For millions of people living with diabetes, systemic disparities are limiting access to healthcare resources, diabetes education, care and technology,” said James R. Gavin III, MD, PhD, clinical professor of medicine at Emory University and chief medical officer of Healing Our Village, Inc. in Atlanta. “By opening the vital gateway to access, including to technology to monitor glucose continuously, we can drive improved health outcomes, stabilize glucose levels and keep people out of the hospital.”

To further address the health and economic disparities, Abbott committed $5 million over three years to support the ADA’s Health Equity Now initiative that champions the right for all people with diabetes to access better care and the latest medical advances. This includes community initiatives and efforts to support low-income Americans – of which more than 75% are made up of people of color – with access to the latest technologies. 

“The COVID-19 pandemic has brought increased attention to the significant health disparities faced by millions of people from low-income and underserved communities across America, and has put a spotlight on the additional challenges faced by the particularly underserved population with diabetes,” said Tracey D. Brown, chief executive officer, American Diabetes Association.

“Access is at the center point of how we can bridge the inequity gap for people with diabetes. Everyone living with diabetes should be able to lead healthy, full lives and that begins with ensuring widespread access to the latest technologies, including continuous glucose monitoring technology.”

Tags: < Corporate Events
ShareTweetShareSend

Related Industries

Healthcare

Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation

January 26, 2023
Healthcare

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

January 25, 2023
Healthcare

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 18, 2023
Healthcare

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023
Healthcare

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders

January 7, 2023
Healthcare

Michelle Quinn Named Acting General Counsel for BD

January 7, 2023

GE Completes Separation of GE HealthCare

January 5, 2023

...

The Ritz-Carlton Leadership Center Appoints Amanda Joiner as New Global Vice President

January 11, 2023

...

chevron names mark a. nelson vice chairman

January 27, 2023

...

Ford Joins the Virtual Power Plant Partnership as a Founding Member to Support Grid Resiliency and Emissions Reductions

January 11, 2023

...

Mercedes-Benz to launch global branded high-power charging network, starting in North America

January 6, 2023

...

Intel Board of Directors Appoints Frank D. Yeary as New Independent Chair

January 24, 2023

...

Michelle Quinn Named Acting General Counsel for BD

January 7, 2023

...

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 18, 2023

...

Cargill Announces CFO Transition

January 10, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.